title: Rationale for the development of Sandimmune Neoral.
authors.affiliation: Sandoz Pharma Ltd., Basle, Switzerland.
authors.forename: J
authors.initials: J
authors.lastname: Vonderscher
authors.forename: A
authors.initials: A
authors.lastname: Meinzer
mesh_terms: D000284:Administration, Oral; D000818:Animals; D001646:Bile / Q000378:metabolism; D003106:Colon / Q000378:metabolism; D016572:Cyclosporine / Q000008:administration & dosage / Q000493:pharmacokinetics*; D004655:Emulsions; D006801:Humans; D007408:Intestinal Absorption; D007421:Intestine, Small / Q000378:metabolism; D008823:Micelles; D051381:Rats; D012996:Solutions
chemical_list: D004655:Emulsions; D008823:Micelles; D012996:Solutions; D016572:Cyclosporine